Abstract
This first Special Issue collects fifteen original research and up-to-date review articles addressing the beneficial properties of herbal products, nutrient supplements, dietary regimens, and functional food for the complementary therapy of human pathologies. In these articles, renowned scholars present and discuss the curative effects and the molecular mechanisms of action of nutraceuticals, medicinal herbs, and dietary regimens that have been proven effective in the treatment of cancers, metabolic syndrome, fatty liver disease, hearth arrythmia and neurodegenerative disorders.
Keywords: Natural products, Nutrient supplements, Functional food, Human diseases, Cancer, Neurodegeneration, Metabolic syndrome, Complementary medicine, Herbal medicine
1. Introduction
Nutraceuticals, medicinal herbal products, and diet regimens have been shown to elicit health promoting, preventive and curative effects toward many different pathological conditions, such as cardiovascular diseases,1 the metabolic syndrome,2 and age-related frailty3 including cognitive decline and neurodegenerative disorders.4,5 A variety of nutraceuticals have shown potential anticancer activity via multiple pathways.6,7 Additionally, specific diet regimens such as ketogenic diet and caloric/protein restriction diet have been shown to benefit cancer patients undergoing radio- and chemotherapy and to prevent cancer cachexia.8, 9, 10, 11, 12
Taken together, the whelm of data supporting the benefits of such complementary medical strategies strongly supports their integration in the protocols for the treatment of human pathologies.
2. The special issue at a glance
The Journal of Traditional and Complementary Medicine is committed to providing the community of biomedical scientists and clinicians with a platform for the publication of articles covering a wide range of medical practices, including the use of natural dietary supplements, that are effective in treating diseases as part of an integrative approach.13 In this Special Issue we have collected fifteen original research and up-to-date review articles addressing the historical/traditional use and the beneficial properties of herbal products, nutrient supplements, dietary regimens, and functional food in preventing and combating human pathologies (Table 1).
Table 1.
The selected articles at a glance.
| TOPIC | AUTHORS | TITLE | TYPE OF ARTICLE | FOCUS ON |
|---|---|---|---|---|
| Ketogenic diet | RJ Klement, G Schäfer, RA Sweeney |
A ketogenic diet exerts beneficial effects on body composition of cancer patients during radiotherapy: An interim analysis of the KETOCOMP study | original | Body mass composition in cancer patients undergoing radiotherapy |
| Prostate cancer | S–H Kim, KB Singh, E-R Hahm, BL Lokeshwar, SV Singh |
Withania somnifera root extract inhibits fatty acid synthesis in prostate cancer cells | original | Inhibition of lipidogenesis in cancer cells by Whitania somnifera |
| Colorectal cancer | H-J Shin, D-H Kim, X Zhong, H–W Yum, S-J Kim, K–S Chun, H–K Na, Y-J Surh |
Preventive effects of Korean red ginseng on experimentally induced colitis and colon carcinogenesis | original | Inhibition of inflammation and colon carcinogenesis by Korean Red Ginseng |
| Ovarian cancer | JH Ha, M Jayaraman, R Radhakrishnan, R Gomathinayagam, M Yan, Y–S Song, C Isidoro, DN Dhanasekaran |
Differential effects of thymoquinone on lysophosphatidic acid-induced oncogenic pathways in ovarian cancer cells | original | Inhibition of cell migration by Thymoquinone |
| Ovarian cancer | L Vallino, A Ferraresi, C Vidoni, E Secomandi, A Esposito, DN Dhanasekaran, C Isidoro |
Modulation of non-coding RNAs by resveratrol in ovarian cancer cells: In silico analysis and literature review of the anti-cancer pathways involved | original | Non-coding RNA profiling in Resveratrol-treated cells |
| Cholangiocarcinoma | S Thongchot, M Thanee, W Loilome, A Techasen, T Boonmars, P Sa-Ngiamwibool, A Titapun, P Yongvani, C Isidoro, N Namwat |
Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy | original | Autophagy-mediated cancer cell death induced by Xantohumol |
| Non-Melanoma Skin Cancers (NMSC) | RR Prasad, S Paudel, K Raina, R Agarwal |
Silibinin and non-melanoma skin cancers | review | Inhibition of UVB-induced NMSC by Silibinin |
| Metabolic syndrome | MA Khatuna, S Sato, T Konishi |
Obesity preventive function of novel edible mushroom, Basidiomycetes-X (Echigoshirayukidake): Manipulations of insulin resistance and lipid metabolism | original | Basidiomicetes X powder reduces the adipose tissue and restores insulin sensitivity in obese mice. |
| Metabolic syndrome/PCOS | M Caputo, E Bona, I Leone, MT Samà, A Nuzzo, A Ferrero, G Aimaretti, P Marzullo, F Prodam |
Inositols and metabolic disorders: From farm to bedside | review | Dietary Inositol improves hormonal disequilibrium and insulin sensitization |
| Non-Alcoholic Fatty Liver Disease (NAFLD) | S Panyod, L-Y Sheen | Beneficial effects of Chinese herbs in the treatment of fatty liver diseases | review | Herbal medicine to prevent and counteract fatty liver diseases |
| Non-Alcoholic Fatty Liver Disease (NAFLD) | V Musolino, M Gliozzi, E Bombardelli, S Nucera, C Carresi, J Maiuolo, R Mollace, S Paone, F Bosco, F Scarano, M Scicchitano, R Macrì, S Ruga, MC Zito, E Palma, S Gratteri, M Ragusa, M Volterrani, V Mollace |
The synergistic effect of Citrus bergamia and Cynara cardunculus extracts on vascular inflammation and oxidative stress in non-alcoholic fatty liver disease | Clinical trial | Polyphenol extracts from Bergamot (Citrus bergamia) and Cynara cardunculus improve NAFLD in diabetic patients |
| Cardiac arrhythmias | A Beik, S Joukar, H Najafipour |
A review on plants and herbal components with antiarrhythmic activities and their interaction with current cardiac drugs | review | Herbal compounds with anti-arrhythmic properties |
| Multiple Sclerosis | AD Fuzimoto, F Brigo |
The “Treatise on the spleen and stomach” (Pí Wèi Lùn) as the first record of multiple sclerosis in the medical literature – A hypothesis based on the analysis of clinical presentation and herbal medicine | review | Herbal remedies for inflammatory autoimmune neuro-demyelination |
| Neurodegenerative diseases | A Prasansuklab, JM Brimson, T Tencomnao |
Potential Thai medicinal plants for neurodegenerative diseases: A review focusing on the anti-glutamate toxicity effect | review | Herbal products protecting from glutamate neuronal excitotoxicity |
| Neuroplasticity, neurodegeneration, glioblastoma | L Colucci-D'Amato, G Cimaglia |
Ruta graveolens as a potential source of neuroactive compounds to promote and restore neural functions | review | Neuroprotective function of Ruta graveolens: potential beneficial effects in neurodegeneration and in glioblastoma |
The ketogenic diet, i.e., a high-fat, low-carbohydrate and amino acid rich diet, has been shown to reflect differently on the cellular metabolism of normal and cancer tissue, sensitizing the latter to killing therapies.14,15 Here, R Klement and collaborators studied the impact of the ketogenic diet on the body composition of cancer patients undergoing radiotherapy. They show that a ketogenic diet in association with amino acid supplementation may reduce the fat mass while preserving the skeletal muscle mass in rectal and breast cancer patients. The authors conclude that the ketogenic diet along with ample amino acid intake is safe and can improve the fat-free body mass during radiotherapy in cancer patients.
Free fatty acids (FFAs) have been shown to play a role in the pathogenesis of prostate cancer by altering the metabolism and the proliferation and invasive behavior of prostate cancer cells.16 Accordingly, the serum of patients with prostate cancer features abnormal levels of FFAs.16 Interestingly, there is a continuum of increased levels of serum FFAs along with progression from prostatitis to benign prostate hyperplasia and prostate cancer. This suggests that inhibition of de novo FFA synthesis could be a valuable strategy to prevent the pathogenesis and progression of prostate cancer.17,18 Here, S V Singh and collaborators studied the molecular mechanisms through which the ethanol extract of Withania somnifera root (WRE), a medicinal plant used in Ayurvedic medicine, inhibits the lipidogenesis in human prostate cancer cells. They show that WRE can reduce the intracellular levels of acetyl-CoA, total free fatty acids, and neutral lipid droplets in prostate cancer cells by decreasing the expression of several key enzymes involved in fatty acid metabolism.
Colorectal cancer is among the most common and deadliest cancers in Western countries; its pathogenesis has been linked to life-style diet and chronic inflammation, besides genetic predisposition.19,20 Particularly, chronic inflammatory bowel disease poses a risk of developing colitis-associated cancer, which can be prevented by inhibiting the COX-2 downstream signaling.21 Here, Y-J Surh and collaborators show that Korean Red Ginseng (KRG) can prevent the progression from colitis to colitis-associated colorectal cancer through multiple mechanisms. At molecular level, KRG inhibited the expression of cyclooxygenase-2 (COX-2) and of inducible nitric oxide synthase (iNOS) in experimental models of colitis and colitis-associated colon carcinogenesis. Based on these data, the authors propose KRG as an adjuvant chemopreventive agent for preventing inflammation-associated colorectal cancer.
Ovarian cancer ranks as the fifth most common and as the most lethal gynecologic tumor in women worldwide. The metabolic cross-talk between cancer and stromal cells in the tumor microenvironment (TME) plays a pivotal role in determining the malignant behavior of ovarian cancer cells.22,23 Lysophosphatidic acid (LPA), a lipid growth factor present in high concentration in the TME of ovarian cancer, has been shown to regulate multiple oncogenic pathways24 in ovarian cancer cells and to corrupt the glucose metabolism and the phenotype of cancer associated fibroblasts.25 Here, D N Dhanasekaran and collaborators investigated the ability of Thymoquinone (TQ), a phytotherapeutic from Nigella sativa with anticancer properties, to inhibit LPA-induced oncogenic activation in ovarian cancer cells. TQ was unable to attenuate LPA-stimulated proliferation or metabolic reprogramming in ovarian cancer cells, yet it potently inhibited the basal and LPA-stimulated migratory and invasive capabilities of ovarian cancer cells.
Resveratrol (RV), a polyphenol abundant in grapes, berries, and nuts, is a caloric/protein restriction mimetic and a well-known nutraceutical with anticancer properties.26 RV has been shown to be a strong inducer of autophagy, a homeostatic lysosomal degradation process, in ovarian cancer cells.27 Previous study showed that RV inhibits the migration-response to the inflammatory cytokine IL-6 in ovarian cancer cells via micro-RNA-mediated activation of autophagy.28 Here, C Isidoro and collaborators report the profiling of microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) in ovarian cancer cells exposed to RV. They employed Diana tools and Gene Ontology (GO) pathway analyses along with Pubmed literature search to identify the biochemical pathways and functional processes potentially modulated by the dysregulated miRNAs and lncRNAs. Globally, RV increased the expression of tumor suppressor non-coding RNAs and downregulated the expression of oncogenic non-coding RNAs. The authors concluded that RV could exert its anti-cancer activity via non-coding RNAs epigenetic modulation of the pathways governing cell homeostasis (including glucose metabolism and autophagy), cell proliferation, cell death and cell motility.
Cholangiocarcinoma arises from the malignant transformation of cholangiocytes, the epithelial cells lining the bile ducts. Its pathogenesis and aggressiveness have been associated with the desmoplastic stroma of the hepatobiliary tract, characterized by intense fibrosis and high content of pro-inflammatory cytokines. Previous data showed that Resveratrol can interrupt the release of IL-6 by cancer associated fibroblasts and by doing so it can restore autophagy and limit the proliferation and invasive capabilities of cholangiocarcinoma cells.29 Drugs modulating autophagy have been shown to promote cell death, reduce invasiveness capacity and sensitize cholangiocarcinoma cells to chemotherapy.30,31 Here, N Namwat and collaborators show that Xanthohumol (XH), a flavonoid found in Humulus lupulus, exerts antitumor activity in an experimental animal model of liver fluke cholangiocarcinogenesis by inducing autophagy. On dissecting the molecular mechanisms, it was found that XH induced autophagy-dependent apoptosis in cholangiocarcinoma cells.
Ultraviolet B (UVB) radiation causes DNA aberrations (such as thymine photodimerization), oxidative stress, inflammatory responses, and altered cellular signaling that ultimately contribute to the development of skin cancers, among which Non-Melanoma Skin Cancers (NMSCs) are the most prominent.32 A variety of herbal-derived products have shown the potentiality to protect skin cells from UVB damage.33, 34, 35 In this review article, Agarwal and collaborators summarize the experimental data on the protective and preventive potential of milk thistle plant-derived silymarin and/or silibinin against UVB-induced NMSC in pre-clinical settings. Particularly, silibinin was shown to prevent UVB-induced thymine dimerization, to promote DNA repair, to induce p53-mediated apoptosis in DNA-unrepaired damaged cells, and to trigger an anti-inflammatory response, thus supporting its potential use to prevent and/or manage NMSCs.36,37
The metabolic syndrome refers to a complex pathophysiological condition characterized by obesity and inflammation of visceral adipose tissue, insulin resistance and hyper-glycemia, dyslipidemia with atherosclerosis, and hypertension that associates with increased risk of cardiovascular disease and type 2 diabetes mellitus.38,39 Such a complex and interconnected comorbidities could be targeted by nutraceuticals and/or functional food able to impinge simultaneously on multiple biochemical pathways.40, 41, 42 Here, T Konishi and collaborators present original data showing that the edible Japanese mushroom Echigoshirayukidake (classified as Basidiomycetes X, BDM-X) counteracts typical features of metabolic syndrome such as insulin resistance, Type 2 diabetes, obesity, and adipose inflammation. The experiments were conducted in a genetically defined obese model rat (OLETF, Otsuka Long Evans Tokushima Fatty) supplemented with the BDM-X powder extremely rich of antioxidant polyphenols and of β-glucan. The treatment reduced the adipose tissue, restored insulin sensitivity, and reduced plasma adiponectin. Based on these data, the authors propose BDM-X as a new resource applicable to the functional foods or the complementary biomedicines to prevent metabolic syndrome leading to type 2 diabetes.
Another natural molecule that has shown promises for the management of the metabolic syndrome is Inositol (or myoinositol), which is abundantly found in many fruits.43 In their review article, F Prodam and collaborators point to the role of inositol in the regulation of several hormones with a focus on its dietary intake and the role of the gut microbiota in the intestinal uptake. Inositol acts as an insulin-sensitizing agents and free radical scavengers, and thus improves insulin-resistance and inflammation. To be noted, inositol deficiency may also underlie the Polycystic ovary syndrome (PCOS), characterized by defective oocytes maturation, infertility and menstrual irregularity, which often associates with the metabolic syndrome. Accordingly, supplementation with the isoform D-chiro-inositol helps to manage the metabolic alterations associated with PCOS.44
Linked to the metabolic syndrome is the Non-Alcoholic Fatty Liver Disease (NAFLD), which represents an additional risk factor for cardiovascular diseases.45 Consumption of so-called “Junk food” rich of fat and sugar increases the risk of developing fatty liver disease. Plant-derived polyphenols and flavonoids may represent an ally in the treatment of NAFLD.40 For instance, the essential oil from garlic or from ginger has been shown to improve lipid accumulation, inflammation, and fibrosis in the liver of obese mice fed with high-fat diet.46,47 S Panyoda and L-Y Sheen have reviewed the literature and here list the herbal medicines with the potential to prevent NAFLD.
Insulin resistance and type 2 diabetes mellitus (T2DM) along with adipose inflammation worsen non-alcoholic steatohepatitis further stimulating the fibrotic processes toward NAFLD, and bergamot polyphenols can prevent such progression.40,48, 49, 50 V Mollace and collaborators conducted a randomized, double blind, placebo-controlled clinical study to evaluate the antifibrotic effect of Bergacyn, an innovative formulation combining Bergamot (Citrus bergamia) Polyphenolic Fraction (BPF) and extract of Cynara cardunculus (CyC). The study showed that concomitant administration of BPF and CyC reduced the serum markers of oxidative stress and inflammation while improving liver fibrosis and function in T2DM patients. These preliminary data support the inclusion of this polyphenol formulation in the therapeutic strategy to counteract vascular inflammation and fibrosis in patients suffering from T2DM and NAFLD.
Cardiac arrhythmias (including bradycardia, tachycardia, flutter, fibrillation) are responsible for at least half of sudden cardiac arrests. In their article, H Najafipourb and collaborators have reviewed the literature on the plants and herbal compounds with anti-arrhythmic properties. They found thirty-six herbs or their derivatives that showed potentially effective in the treatment of arrhythmias in animal and cellular models, and for which the mechanism of action had been investigated. The most promising ones were dauricine, an alkaloid from Asiatic Moonseed Rhizome, and sophocarpine, an alkaloid from Sophora flavescens, that inhibit cardiac transmembrane Na+, K+, and Ca2+ ion currents thus prolonging the action potential duration and effective refractory period.51,52 The authors also warn on the possible synergistic interaction of certain herbal components (e.g., Hawthorn, Licorice and Ginseng) with cardiac glycosides.
Multiple sclerosis (MS) is an inflammatory autoimmune-mediated neurological disorder characterized by axon demyelination in the central nervous system. The pathology was well described in details with histological and clinical correlates by Jean-Martin Charcot in 1868, who introduced the term “la sclérose en plaques” for the focal damages in the white and gray matter tissues caused by infiltration of immune and inflammatory cells.53,54 Here, in their interesting review article A Fuzimoto and F Brigo trace the history of the description of the disease and make an interesting comparison with the first description of MS-related symptoms given by the Chinese physician Li Gao (who lived in 1180–1251, during the Jin dynasty). The authors made an excellent search on the effective curative potential and the molecular mechanisms of action of the herbal remedies (the ones more effective are Astragali radix, Ginseng radix, Glycyrrhizae radix, and Berberine) proposed by Li Gao in his treatise Pí Wèi Lùn (脾胃论 “Treatise on Spleen and Stomach”) to manage this invalidating neurological disorder.
Chronic and age-related neurodegenerative diseases (e.g., Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, fronto-temporal dementia, others) are associated with progressive neuronal loss in the central nervous system. Excitotoxicity and pro-oxidant free radicals may lead to neuronal cell death through inhibition of the autophagy-lysosomal clearance of damaged mitochondria and of abnormally folded neuroproteins that eventually accumulate in the cells.55, 56, 57 A variety of nutraceuticals and herbal-derived compounds have been shown neuroprotective activity in experimental in vitro and in vivo models of neurodegenerative diseases.58,59 As glutamate is a major excitatory neurotransmitter in the brain, oxidative stress linked to excessive glutamate is believed to play a major role in neurotoxicity and neurodegeneration.60 Here, Tencomnao and collaborators present a comprehensive review of the medicinal plants with anti-glutamate toxicity properties. In particular, they focus on six candidate plant species of Thailand (namely, Acanthus ebracteatus, Cleistocalyx nervosum, Pueraria mirifica, Rhinacanthus nasutus, Streblus asper, Bacopa monnieri) that could be a promising resource for prevention and complementary therapy of neurodegenerative diseases, describing their active constituents and mechanism of action against glutamate toxicity-mediated neuronal cell death.
Promoting neuroplasticity is another therapeutic strategy to slow down age-related neurodegeneration,61 and a variety of nutraceuticals have been shown promising in restoring brain function after neuronal injury.62 In this contest, Ruta graveolens is gaining attention because of its content of neuroactive compounds potentially able to promote neuroprotection. Here, L. Colucci-D'Amato and G. Cimaglia have reviewed the neuroprotective properties and the mechanisms of action of rutin, the most abundant bioactive component of Ruta graveolens, in a variety of experimental settings of neurodegeneration.
3. Concluding remarks
Nutraceuticals are natural compounds found in dietary aliments that have nutritional and therapeutic potentials to prevent or cure pathological conditions as well as to improve health and longevity, and to promote the quality of life.63
The articles collected in this Special Issue of the Journal of Traditional and Complementary Medicine add to our knowledge on the health benefits provided by specific dietary regimen, nutrient supplements, herbal nutraceuticals and edible mushrooms for the cure of cancer, metabolic syndrome, fatty liver disease, cardiovascular diseases and neurodegenerative diseases.
These studies provide the scientific ground for and encourage the implementation of preventive and curative strategies based on the inclusion of nutraceuticals, dietary regimens, and a healthy lifestyle in an integrative approach to treat the disease and, overall, the patient.
Acknowledgements
The author is grateful to Dr Ashley Chang, Managing Editor of the Journal of Traditional and Complementary Medicine (National Taiwan University, Taipei, TW) for editorial assistance, and to Dr Alessandra Ferraresi and Dr Letizia Vallino (Università del Piemonte Orientale, Novara, Italy) for preparation of the Graphical Abstract and assistance in literature search and formatting of the manuscript.
Footnotes
Peer review under responsibility of The Center for Food and Biomolecules, National Taiwan University.
References
- 1.Banez M.J., Geluz M.I., Chandra A. A systemic review on the antioxidant and anti-inflammatory effects of resveratrol, curcumin, and dietary nitric oxide supplementation on human cardiovascular health [published online ahead of print, 2020 Mar 10] Nutr Res. 2020;78:11-26. doi: 10.1016/j.nutres.2020.03.002. [DOI] [PubMed] [Google Scholar]
- 2.Mirabelli M., Chiefari E., Arcidiacono B. Mediterranean diet nutrients to turn the tide against insulin resistance and related diseases. Nutrients. 2020 Apr 12;12(4):1066. doi: 10.3390/nu12041066. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Leri M., Scuto M., Ontario M.L. Healthy effects of plant polyphenols: molecular mechanisms. Int J Mol Sci. 2020 Feb 13;21(4):1250. doi: 10.3390/ijms21041250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Devi S.A., Chamoli A. Polyphenols as an effective therapeutic intervention against cognitive decline during normal and pathological brain aging. Adv Exp Med Biol. 2020;1260:159–174. doi: 10.1007/978-3-030-42667-5_7. [DOI] [PubMed] [Google Scholar]
- 5.Angeloni C., Businaro R., Vauzour D. The role of diet in preventing and reducing cognitive decline. Curr Opin Psychiatr. 2020;33(4):432-438. doi: 10.1097/YCO.0000000000000605. [DOI] [PubMed] [Google Scholar]
- 6.Calvani M., Pasha A., Favre C. Nutraceutical boom in cancer: inside the labyrinth of reactive oxygen species. Int J Mol Sci. 2020 Mar 12;21(6):1936. doi: 10.3390/ijms21061936. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Vidoni C., Ferraresi A., Secomandi E., Vallino L., Dhanasekaran D.N., Isidoro C. Epigenetic targeting of autophagy for cancer prevention and treatment by natural compounds [published online ahead of print, 2019 May 2] Semin Canc Biol. 2019;S1044–579X(19) doi: 10.1016/j.semcancer.2019.04.006. 30010-0. [DOI] [PubMed] [Google Scholar]
- 8.Hagihara K., Kajimoto K., Osaga S. Promising effect of a new ketogenic diet regimen in patients with advanced cancer. Nutrients. 2020 May 19;12(5):E1473. doi: 10.3390/nu12051473. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Lévesque S., Pol J.G., Ferrere G., Galluzzi L., Zitvogel L., Kroemer G. Trial watch: dietary interventions for cancer therapy. OncoImmunology. 2019;8(7):1591878. doi: 10.1080/2162402X.2019.1591878. Published 2019 Apr 3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Calvaruso M., Pucci G., Musso R. Nutraceutical compounds as sensitizers for cancer treatment in radiation therapy. Int J Mol Sci. 2019;20(21):5267. doi: 10.3390/ijms20215267. Published 2019 Oct 23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Kang J.S. Dietary restriction of amino acids for Cancer therapy. Nutr Metab. 2020 Mar 14;17:20. doi: 10.1186/s12986-020-00439-x. eCollection 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Ukovic B., Porter J. Nutrition interventions to improve the appetite of adults undergoing cancer treatment: a systematic review. Support Care Canc. 2020 May 25 doi: 10.1007/s00520-020-05475-0. [DOI] [PubMed] [Google Scholar]
- 13.Isidoro C., Huang C.C., Sheen L.Y. Report from the second international conference of traditional and complementary medicine on health 2015. J Tradit Compl Med. 2016;6(1):5-9. doi: 10.1016/j.jtcme.2016.01.001. Published 2016 Jan 16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Weber D.D., Aminzadeh-Gohari S., Tulipan J., Catalano L., Feichtinger R.G., Kofler B. Ketogenic diet in the treatment of cancer - where do we stand? Mol Metab. 2020;33:102-121. doi: 10.1016/j.molmet.2019.06.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Klement R.J., Brehm N., Sweeney R.A. Ketogenic diets in medical oncology: a systematic review with focus on clinical outcomes. Med Oncol. 2020;37(2):14. doi: 10.1007/s12032-020-1337-2. Published 2020 Jan 11. [DOI] [PubMed] [Google Scholar]
- 16.Ha X., Wang J., Chen K. Free fatty acids promote the development of prostate cancer by upregulating peroxisome proliferator-activated receptor gamma. Canc Manag Res. 2020;12:1355-1369. doi: 10.2147/CMAR.S236301. Published 2020 Feb 24. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 17.Singh K.B., Singh S.V. Fatty acid synthesis intermediates represent novel noninvasive biomarkers of prostate cancer chemoprevention by phenethyl isothiocyanate. Canc Prev Res. 2017;10(5):279-289. doi: 10.1158/1940-6207.CAPR-17-0001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Singh K.B., Kim S.H., Hahm E.R., Pore S.K., Jacobs B.L., Singh S.V. Prostate cancer chemoprevention by sulforaphane in a preclinical mouse model is associated with inhibition of fatty acid metabolism. Carcinogenesis. 2018 May 28;39(6):826–837. doi: 10.1093/carcin/bgy051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Ngui I.Q.H., Perera A.P., Eri R. Does NLRP3 inflammasome and aryl hydrocarbon receptor play an interlinked role in bowel inflammation and colitis-associated colorectal cancer? Molecules. 2020 May 22;25(10):E2427. doi: 10.3390/molecules25102427. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Lichtenstern C.R., Ngu R.K., Shalapour S., Karin M. Immunotherapy, inflammation and colorectal cancer. Cells. 2020 Mar 4;9(3):618. doi: 10.3390/cells9030618. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Lee J.S., Kim H.S., Hahm K.B., Surh Y.J. Effects of genetic and pharmacologic inhibition of COX-2 on colitis-associated carcinogenesis in mice. J Cancer Prev. 2020 Mar 30;25(1):27–37. doi: 10.15430/JCP.2020.25.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Thuwajit C., Ferraresi A., Titone R., Thuwajit P., Isidoro C. The metabolic cross-talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: autophagy plays a role. Med Res Rev. 2018;38(4):1235-1254. doi: 10.1002/med.21473. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Ghoneum A., Afify H., Salih Z., Kelly M., Said N. Role of tumor microenvironment in ovarian cancer pathobiology. Oncotarget. 2018;9(32):22832–22849. doi: 10.18632/oncotarget.25126. Published 2018 Apr 27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Ha J.H., Ward J.D., Radhakrishnan R., Jayaraman M., Song Y.S., Dhanasekaran D.N. Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gαi2, Src, and HIF1α signaling nexus. Oncotarget. 2016 Jun 21;7(25):37664–37679. doi: 10.18632/oncotarget.9224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Radhakrishnan R., Ha J.H., Jayaraman M. Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts. Canc Lett. 2019;442:464-474. doi: 10.1016/j.canlet.2018.11.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Meng X., Zhou J., Zhao C.N., Gan R.Y., Li H.B. Health benefits and molecular mechanisms of resveratrol: a narrative review. Foods. 2020 Mar 14;9(3):340. doi: 10.3390/foods9030340. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Ferraresi A., Titone R., Follo C. The protein restriction mimetic Resveratrol is an autophagy inducer stronger than amino acid starvation in ovarian cancer cells. Mol Carcinog. 2017;56(12):2681-2691. doi: 10.1002/mc.22711. [DOI] [PubMed] [Google Scholar]
- 28.Ferraresi A., Phadngam S., Morani F. Resveratrol inhibits IL-6-induced ovarian cancer cell migration through epigenetic up-regulation of autophagy. Mol Carcinog. 2017;56(3):1164-1181. doi: 10.1002/mc.22582. [DOI] [PubMed] [Google Scholar]
- 29.Thongchot S., Ferraresi A., Vidoni C. Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells [published correction appears in Cancer Lett. Canc Lett. 2018 Oct 10;434:206–207. doi: 10.1016/j.canlet.2018.05.031. 2018;430:160-171. [DOI] [PubMed] [Google Scholar]
- 30.Thongchot S., Vidoni C., Ferraresi A. Dihydroartemisinin induces apoptosis and autophagy-dependent cell death in cholangiocarcinoma through a DAPK1-BECLIN1 pathway. Mol Carcinog. 2018;57(12):1735-1750. doi: 10.1002/mc.22893. [DOI] [PubMed] [Google Scholar]
- 31.Perez-Montoyo H. Therapeutic potential of autophagy modulation in cholangiocarcinoma. Cells. 2020 Mar 4;9(3):614. doi: 10.3390/cells9030614. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.D'Orazio J., Jarrett S., Amaro-Ortiz A., Scott T. UV radiation and the skin. Int J Mol Sci. 2013;14(6):12222–12248. doi: 10.3390/ijms140612222. Published 2013 Jun 7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Thongrakard V., Ruangrungsi N., Ekkapongpisit M., Isidoro C., Tencomnao T. Protection from UVB toxicity in human keratinocytes by Thailand native herbs extracts. Photochem Photobiol. 2014;90(1):214-224. doi: 10.1111/php.12153. [DOI] [PubMed] [Google Scholar]
- 34.de Silva M.B., Tencomnao T. The protective effect of some Thai plants and their bioactive compounds in UV light-induced skin carcinogenesis. J Photochem Photobiol, B. 2018 Aug;185:80–89. doi: 10.1016/j.jphotobiol.2018.04.046. Epub 2018 May 2. [DOI] [PubMed] [Google Scholar]
- 35.Sharma P., Montes de Oca M.K., Alkeswani A.R. Tea polyphenols for the prevention of UVB-induced skin cancer. Photodermatol Photoimmunol Photomed. 2018 Jan;34(1):50–59. doi: 10.1111/phpp.12356. Epub 2017 Nov 20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Guillermo-Lagae R., Deep G., Ting H., Agarwal C., Agarwal R. Silibinin enhances the repair of ultraviolet B-induced DNA damage by activating p53-dependent nucleotide excision repair mechanism in human dermal fibroblasts. Oncotarget. 2015 Nov 24;6(37):39594–39606. doi: 10.18632/oncotarget.5519. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Rigby C.M., Roy S., Deep G. Role of p53 in silibinin-mediated inhibition of ultraviolet B radiation-induced DNA damage, inflammation and skin carcinogenesis. Carcinogenesis. 2017 Jan;38(1):40–50. doi: 10.1093/carcin/bgw106. Epub 2016 Oct 11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Huang P.L. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2(5-6):231-237. doi: 10.1242/dmm.001180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Genoni G., Menegon V., Secco G.G. Insulin resistance, serum uric acid and metabolic syndrome are linked to cardiovascular dysfunction in pediatric obesity. Int J Cardiol. 2017 Dec 15;249:366–371. doi: 10.1016/j.ijcard.2017.09.031. Epub 2017 Sep. 14. [DOI] [PubMed] [Google Scholar]
- 40.Parafati M., Lascala A., Morittu V.M. Bergamot polyphenol fraction prevents nonalcoholic fatty liver disease via stimulation of lipophagy in cafeteria diet-induced rat model of metabolic syndrome. J Nutr Biochem. 2015 Sep;26(9):938–948. doi: 10.1016/j.jnutbio.2015.03.008. Epub 2015 Apr 28. [DOI] [PubMed] [Google Scholar]
- 41.Capomolla A.S., Janda E., Paone S. Atherogenic index reduction and weight loss in metabolic syndrome patients treated with A novel pectin-enriched formulation of bergamot polyphenols. Nutrients. 2019 Jun 4;11(6):1271. doi: 10.3390/nu11061271. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Kim C.H., Wheatley-Guy C.M., Stewart G.M., Yeo D., Shen W.K., Johnson B.D. The impact of pulsed electromagnetic field therapy on blood pressure and circulating nitric oxide levels: a double blind, randomized study in subjects with metabolic syndrome. Blood Pres. 2020;29(1):47-54. doi: 10.1080/08037051.2019.1649591. [DOI] [PubMed] [Google Scholar]
- 43.Clements R.S., Jr., Darnell B. Myo-inositol content of common foods: development of a high-myo-inositol diet. Am J Clin Nutr. 1980;33(9):1954-1967. doi: 10.1093/ajcn/33.9.1954. [DOI] [PubMed] [Google Scholar]
- 44.Davinelli S., Nicolosi D., Di Cesare C., Scapagnini G., Di Marco R. Targeting metabolic consequences of insulin resistance in polycystic ovary syndrome by D-chiro-inositol and emerging nutraceuticals: a focused review. J Clin Med. 2020;9(4):987. doi: 10.3390/jcm9040987. Published 2020 Apr 2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Kumar R., Priyadarshi R.N., Anand U. Non-alcoholic fatty liver disease: growing burden, adverse outcomes and associations. J Clin Transl Hepatol. 2020;8(1):76-86. doi: 10.14218/JCTH.2019.00051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Lai Y.S., Chen W.C., Ho C.T. Garlic essential oil protects against obesity-triggered non-alcoholic fatty liver disease through modulation of lipid metabolism and oxidative stress. J Agric Food Chem. 2014 Jun 25;62(25):5897–5906. doi: 10.1021/jf500803c. Epub 2014 Jun 11. [DOI] [PubMed] [Google Scholar]
- 47.Lai Y.S., Lee W.C., Lin Y.E. Ginger essential oil ameliorates hepatic injury and lipid accumulation in high fat diet-induced non-alcoholic fatty liver disease. J Agric Food Chem. 2016 Mar 16;64(10):2062–2071. doi: 10.1021/acs.jafc.5b06159. [DOI] [PubMed] [Google Scholar]
- 48.Parafati M., Lascala A., La Russa D. Bergamot polyphenols boost therapeutic effects of the diet on non-alcoholic steatohepatitis (NASH) induced by "Junk food": evidence for anti-inflammatory activity. Nutrients. 2018;10(11):1604. doi: 10.3390/nu10111604. Published 2018 Nov 1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Musolino V., Gliozzi M., Scarano F. Bergamot polyphenols improve dyslipidemia and pathophysiological features in a mouse model of non-alcoholic fatty liver disease. Sci Rep. 2020;10(1):2565. doi: 10.1038/s41598-020-59485-3. Published 2020 Feb 13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Carresi C., Gliozzi M., Musolino V. The effect of natural antioxidants in the development of metabolic syndrome: focus on bergamot polyphenolic fraction. Nutrients. 2020;12(5):E1504. doi: 10.3390/nu12051504. Published 2020 May 21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Qian J.Q. Cardiovascular pharmacological effects of bisbenzylisoquinoline alkaloid derivatives. Acta Pharmacol Sin. 2002;23(12):1086-1092. [PubMed] [Google Scholar]
- 52.Yang Z.F., Li C.Z., Wang W. Electrophysiological mechanisms of sophocarpine as a potential antiarrhythmic agent. Acta Pharmacol Sin. 2011;32(3):311-320. doi: 10.1038/aps.2010.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Ghasemi N., Razavi S., Nikzad E. Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy. Cell J. 2017;19(1):1-10. doi: 10.22074/cellj.2016.4867. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Grzegorski T., Losy J. Multiple sclerosis - the remarkable story of a baffling disease. Rev Neurosci. 2019;30(5):511-526. doi: 10.1515/revneuro-2018-0074. [DOI] [PubMed] [Google Scholar]
- 55.Isidoro C., Biagioni F., Giorgi F.S., Fulceri F., Paparelli A., Fornai F. The role of autophagy on the survival of dopamine neurons. Curr Top Med Chem. 2009;9(10):869-879. [PubMed] [Google Scholar]
- 56.Janda E., Isidoro C., Carresi C., Mollace V. Defective autophagy in Parkinson's disease: role of oxidative stress. Mol Neurobiol. 2012 Dec;46(3):639–661. doi: 10.1007/s12035-012-8318-1. Epub 2012 Aug 17. [DOI] [PubMed] [Google Scholar]
- 57.Vidoni C., Follo C., Savino M., Melone M.A., Isidoro C. The role of cathepsin D in the pathogenesis of human neurodegenerative disorders. Med Res Rev. 2016 Sep;36(5):845–870. doi: 10.1002/med.21394. Epub 2016 Apr 26. [DOI] [PubMed] [Google Scholar]
- 58.Vidoni C., Secomandi E., Castiglioni A., Melone M.A.B., Isidoro C. Resveratrol protects neuronal-like cells expressing mutant Huntingtin from dopamine toxicity by rescuing ATG4-mediated autophagosome formation. Neurochem Int. 2018 Jul;117:174–187. doi: 10.1016/j.neuint.2017.05.013. Epub 2017 May 19. [DOI] [PubMed] [Google Scholar]
- 59.Oppedisano F., Maiuolo J., Gliozzi M. The potential for natural antioxidant supplementation in the early stages of neurodegenerative disorders. Int J Mol Sci. 2020;21(7):2618. doi: 10.3390/ijms21072618. Published 2020 Apr 9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Lau A., Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflügers Archiv. 2010;460(2):525-542. doi: 10.1007/s00424-010-0809-1. [DOI] [PubMed] [Google Scholar]
- 61.Schaefers A.T., Teuchert-Noodt G. Developmental neuroplasticity and the origin of neurodegenerative diseases. World J Biol Psychiatr. 2016;17(8):587-599. doi: 10.3109/15622975.2013.797104. [DOI] [PubMed] [Google Scholar]
- 62.Gite S., Ross R.P., Kirke D. Nutraceuticals to promote neuronal plasticity in response to corticosterone-induced stress in human neuroblastoma cells. Nutr Neurosci. 2019;22(8):551-568. doi: 10.1080/1028415X.2017.1418728. [DOI] [PubMed] [Google Scholar]
- 63.Sachdeva V., Roy A., Bharadvaja N. Current prospective of nutraceuticals: a review. Curr Pharmaceut Biotechnol. 2020 Jan 29 doi: 10.2174/1389201021666200130113441. [DOI] [PubMed] [Google Scholar]
